Cambridge, MA, United States of America

Zhen Xing

USPTO Granted Patents = 2 

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Zhen Xing in Trispecific Binding Proteins

Introduction

Zhen Xing is an accomplished inventor based in Cambridge, MA, known for his groundbreaking work in the field of biomedical sciences. With two notable patents to his name, Zhen's innovations contribute significantly to the development of advanced therapeutic solutions. His research focuses on trispecific binding proteins, paving the way for novel treatments targeting various diseases.

Latest Patents

Zhen Xing's latest patents revolve around trispecific and/or trivalent binding proteins comprising four polypeptide chains, which form three antigen binding sites that specifically bind to one or more target proteins. These include configurations designed to bind CD28 polypeptides, CD3 polypeptides, and even specific tumor target proteins. Remarkably, some embodiments of these binding proteins are tailored to recognize and bind HIV target proteins, showcasing the potential for applications in viral therapies. The patents also outline methods for synthesizing these innovative binding proteins and their various uses in medical applications, reflecting Zhen's commitment to addressing pressing healthcare challenges.

Career Highlights

Currently, Zhen is affiliated with Sanofi, where he continues to push the boundaries of biomolecular innovation. His expertise in engineering binding proteins that exhibit high specificity and versatility has positioned him as a key contributor in the field, helping to advance therapeutic research and development initiatives.

Collaborations

Zhen has collaborated with notable colleagues such as Christian Beil and Jochen Beninga, combining their talent and expertise to enhance the research endeavors at Sanofi. These partnerships are pivotal in fostering a collaborative research environment that accelerates the discovery and implementation of innovative therapeutic solutions.

Conclusion

In summary, Zhen Xing stands as a prominent figure in biomedical innovation. With his contributions to the understanding and development of trispecific binding proteins, he is undoubtedly making a significant impact in the field of therapeutic research. Through his collaborations and continued dedication, Zhen is set to influence the future of medicine and improve patient outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…